Adare Pharmaceuticals, a clinical-stage pharmaceutical company, completed the acquisition of Orbis Biosciences, a pharmaceutical technology company. Financial terms were not disclosed. "The acquisition by Adare will globalize the reach of our technologies and services. Orbis’s focus on precision delivery solutions has enabled us to develop expertise in novel extended-release and pulsatile-release formulations and to collaborate with great partners. We are pleased to join Adare, an industry leader in drug formulation development and manufacturing," Maria Flynn, Orbis Biosciences President and CEO.